Skip to content

Reduce the relapse risk in alcohol use disorder

Effectiveness of individualized homoeopathic medicines in reducing relapse risk in patients with alcohol use disorder -a quasi experimental study - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/089334
Enrollment
38
Registered
2025-06-23
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F10- Alcohol related disorders

Interventions

Intervention1: Individualized homoeopathic medicines.: After enrollment the case will be repertorised. Appropriate potentized Individualised Homoeopathic Medicine will be administered in minimum dose

Sponsors

DR KRISHNA VENI K
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Diagnosed cases of alcohol use disorder 303.9 as per DSM V criteria. 2.Participants in both gender age group between 19-65 years. 3.Participants with severity of alcohol dependence questionnaire score above 16.

Exclusion criteria

Exclusion criteria: 1.Participants who currently undergoing any psychotherapies such as cognitive behaviour therapy and dialectical behaviour therapy. 2.Non pathological drinker. 3.Participants in the withdrawal period. 4.Cases with serious life-threatening medical conditions. 5.Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
ARRS- The Alcohol Relapse Risk Scale will be administered every three months to assess the overall risk of relapse in the study population, with the aim of observing a reduction in the ARRS score, indicating a decreased risk of relapse.Timepoint: Every three months from baseline till the conclusion of study.

Secondary

MeasureTime frame
1.ARRS-Alcohol relapse risk scale is administered every three months to identify the most common cause of relapse in alcohol use disorder. 2.SADQ Severity of Alcohol Dependence Questionnaire will be administered three months to assess the overall severity of alcohol dependence in the study population. The aim is to observe a reduction in the SADQ score, indicating a decrease in the severity of alcohol dependence By using these outcome measures, the study aims to evaluate the effectiveness of individualized homoeopathic medicines in reducing the risk of relapse (as measured by the ARRS) and the overall severity of alcohol dependence (as measured by the SADQ) in the study population. The desired outcome is a reduction in the scores on these measures, indicating a positive response to the homoeopathic intervention. Timepoint: Every three months from baseline till the conclusion of study.

Countries

India

Contacts

Public ContactDr R Bhuvaneswari

National homoeopathy research institute in mental health,kottayam,kerala.

dr.bhuvaneswarir@gmail.com8281475541

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026